Neurones: 6.3% Net Profit In 1St Half 2025

2025-09-10 11:46:18

(MENAFN- GlobeNewsWire - Nasdaq) PRESS INFORMATION
Heading: 1^st half 2025 results Nanterre, September 10, 2025 (after trading)

6.3% net profit in 1 ^st half 2025

(in millions of euros)	H1 2024	2024	H1 2025 *
Revenues	402.4	810.4	424.3
Business operating profit **	40.5 (10.1%)	84.1 (10.4%)	37.4 (8.8%)
Operating profit	37.1 (9.2%)	77.9 (9.6%)	33.1 (7.8%)
Net financial profit	4.7	10.2	4.8
Income tax	(12.6)	(24.9)	(11.1)
Net profit after tax	29.2 (7.3%)	63.2 (7.8%)	26.8 (6.3%)
of which, group share	24.5	52.5	22.7
Net cash excluding financial debt ***	256.9	319.5	282.2
Staff at end of period (ppl)	7,001	7,087	7,264

* Financial statements as of June 30, 2025, approved by the Board of Directors on September 10.
** Before cost of bonus shares.
*** Excluding IFRS16 lease liabilities.

Achievements

As previously announced, the Group posted growth of 5.4% in the first half of the year (including 4.6% with constant structures), despite an unfavorable economic environment.

At the end of the first half-year:

operating profit was confirmed at 7.8% after new social security and tax charges (approximately 0.4% of revenues). It mainly reflects pressure on gross margins (price pressure, slight increase in inter-contract periods, etc.);
net profit, group share, amounted to 5.3% of revenues;
net cash (excluding IFRS 16 lease liabilities) increased by €25.3 million compared to June 30, 2024.

Outlook

In a persistently uncertain climate, NEURONES confirms its latest forecasts for the full year:

revenues of nearly €850 million,
operating profit of approximately 8%.

About NEURONES
With over 7,250 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment A - NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible

Press Relations:
O'Connection
Julia Philippe-Brutin
Tel.: +33 (0)6 03 63 06 03
...

NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
...

Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
...

Attachment

neurones-first-half-2025-results

MENAFN10092025004107003653ID1110044119

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.